Gliomas

• CLINICAL_TRIALS research · 2026-04-06
  Clinical Trial Update: Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma [NA]

  A clinical trial update indicates Alpha Tau Medical's DaRT alpha radiation emitter device is being studied for recurrent glioblastoma and re…

• CLINICAL_TRIALS research · 2026-02-27
  Clinical Trial Update: Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas [EARLY_Phase 1]

  This clinical trial update indicates that an early-phase window-of-opportunity study of ulixertinib for MAPK-activated gliomas is currently …

• CLINICAL_TRIALS research · 2025-09-30
  Clinical Trial Update: AI-assisted Diagnosis of Malignant Brain Tumors

  An AI-assisted diagnostic study for malignant brain tumors is currently recruiting at Zhejiang University. The trial focuses on leveraging A…

• CLINICAL_TRIALS research · 2025-02-14
  Clinical Trial Update: A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 Expression [EARLY_Phase 1]

  This is an early-phase, single-arm trial testing allogeneic CD70-directed CAR-T cells in patients with relapsed or refractory gliomas that e…